Abstract
Diabetes represents the primary cause of non-traumatic amputation in the western world (1). It is estimated that approximately 25% of subjects with diabetes will, over the course of their lives, experience problems with their feet and that one-third of these patients will undergo amputation (2–4). Although these data highlight the extent of this problem in the diabetic population, they do not necessarily predicate inevitability: on the contrary, they serve to demonstrate that simple and relatively inexpensive measures may be able to reduce the number of amputations by up to 85% (5–9). Some clinical conditions put the diabetic patient “at risk of ulceration.” An awareness of these conditions and the identification of subjects at risk may permit the introduction of suitable preventive strategies (10–13).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes, in Diabetes in America, 2nd ed. (Harris MI, Cowie CC, Stern MP, et al., eds.), Washington, DC, US Government Printing Office, 1995, pp. 232–238.
Centers for Disease Control. Diabetes Surveillance, 1993. US Department of Health and Human Services, Atlanta, GA, 1993.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:513–521.
Moss SE, Klein BEK. The prevalence and incidence of lower extremity amputation in diabetic population. Arch Intern Med 1992;152:610–616.
Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1993;119:36–41.
Edmonds ME, Foster A, Watkins PJ. Can careful foot care in the diabetic patient prevent major amputation? in Limb Salvage and Amputation for Vascular Disease (Greenhalgh RM, Jamieson CW, Nicolaides AN, eds.), WB Saunders, Philadelphia, 1988, pp. 407–417.
Davidson JK, Alogna M, Goldsmith M, Borden J. Assessment of program effectiveness at Grady Memorial Hospital-Atlanta, in Educating Diabetic Patients (Steiner G, Lawrence PA, eds.), Springer, New York, 1981, pp. 329–348.
Runyan JW Jr, Van der Zwaag R, Joiner MB, Miller ST. The Memphis Diabetes Continuing Care Program. Diabetes Care 1980;3:382–386.
Assal JP, Muhlhauser I, Pernet A, Gfeller R, Jorgens V, Berger M. Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 1985;28:602–613.
Boulton AJM, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986;3:335–337.
Sims DS Jr, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot. J Am Phys Ther Assoc 1988;68:1887–1902.
Lavery LA, Armstrong DG, Vela SA, Quebedeaux JL, Fleischli J. Practical criteria for screening patients at high risk for diabetic foot ulcerations. Arch Intern Med 1998;158:157–162.
McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and education program. Diabet Med 1998;15:80–84.
Young MJ, Breddly JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care 1994;17:557–560.
McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 1995;18:216–219.
Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two setting. Diabetes Care 1999;22:157–162.
Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1982;16:1446–1452.
Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabetes Complications 1990;4:21–25.
Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;20:1273–1278.
Birke JA, Sims DS. Plantar sensory threshold in ulcerative foot. Lepr Rev 1986;57:216–267.
Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990;13: 1057–1061.
Kumar S, Fernando DJS, Veves A, et al. Semmes Weinstein monofilaments: a simple, effective and inexpensive screening device for identifyng diabetic patients at risk of foot ulceration. Diabetes Care 1991;13:63–68.
Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lowerextremity amputation in a primary health care setting. Diabetes Care 1992;15:1386–1389.
Cavanagh PR, Simoneau GG, Ulbrecht JS. Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomechanics 1993;26:23–40.
Coughlin MS. Mallet toes, hammer toes, claw toes, and corns: causes and treatments of lesser toe deformities. Postgrad Med 1984;75:191–198.
Habershaw G, Donovan JC. Biomechanical considerations of the diabetic foot, in Management of Diabetic Foot Problems (Kozak GP, Hoar CS, Rowbotham JL, et al., eds.), WB Saunders, Philadelphia, 1984, pp. 32–44.
Ctercteko GC, Dhanendran M, Hutton WC, Lequesne LP. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981;68:608–614.
Boulton AJM, Betts RP, Franks CI, Ward JD, Duckworth T. The natural history of foot pressure abnormalities in neuropathic diabetic subjects. Diabet Res 1987;5:73–77.
Gooding GAW, Stess RM, Graf PM. Sonography of the sole of the foot: evidence for loss of foot pad thickness in diabetes and its relationship to ulceration of the foot. Invest Radiol 1986;21:45–48.
Young MJ, Cavanagh PR, Thomas G, et al. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med Suppl 1992;9:55–57.
Veves A, Murray HJ, Young MJ, Boulton AJM. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660–663.
Masson EA, Hay EM, Stockley I, et al. Abnormal foot pressures alone may not cause ulceration. Diabet Med 1989;6:426–428.
Lavery LA, Armstrong DG, Vela SA, Quebedeax TL, Fleischli JC. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157–162.
Mingardi R, Pasqualetti P, Strazzabosco M, et al. Risk factors for ulceration, amputation, death in a diabetic out-patients clinic. Diabetologia 2000;43(Suppl 1):A243.
Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1999;21:2161–2177.
Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 1997;40:1062–1069.
Andersen H, Poulsen PL, Mogensen CE, Jakobsen J. Isokinetic muscle strength in longterm IDDM patients in relation to diabetic complications. Diabetes 1996;45:440–445.
Payne CB. Biomechanics of the foot in diabetes mellitus. Some theoretical considerations. J Am Podiatr Med Assoc 1998;88:285–289 relief of plantar pressure in diabetic patients. Diabet Med 1998;15:518–522.
Delbrid L, Appleberg M, Reeve TS. Factors associated with development of foot lesions in the diabetic. Surgery 1983;93;1:78–82.
Kastenbauer T, Sokol G, Auinger M, Irsigler K. Running shoes for relief of plantar pressure in diabetic patients. Diabet Med 1998;15:518–522.
Ashry HR, Lavery LA, Murdoch DP, Frolich M, Lavery DC. Effectiveness of diabetic insoles to reduce foot pressures. J Foot Ankle Surg 1997;36:268–271.
Mueller MJ. Therapeutic footwear helps protect the diabetic foot. JAm Podiatr Med Assoc 1997;87:360–364.
Lavery LA, Vela SA, Fleischli JG, Armstrong DG, Lavery DC. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 1997;20:1706–1710.
Tovey FI. The manufacture of diabetic footwear. Diabet Med 1984;1:69–71.
Mueller MJ, Strube MJ, Allen BT. Therapeutic footwear can reduce plantar pressure in patients with diabetes and transmetatarsal amputation. Diabetes Care 1997;20:637–641.
Cavanagh PR, Ulbrecht JS, Caput GM. Biomechanical aspects of diabetic foot desease: aetiology, treatment and prevention. Diabet Med 1996;13(Suppl):517–522.
Lord M, Riad H. Pressure redistribution by molded inserts in diabetic footwear: a pilot study. J Rehabil Res Dev 1994;31:214–221.
Mueller MJ. Application of plantar pressure assessment in footwear and insert design. J Orthop Sports Phys Ther 1999;29:745–755.
Foto JG, Birke J. Evaluation of multidensity orthotic materials used in footwear for patients with diabetes. Foot Ankle Int 1998;19:836–841.
Brand PW. Repetitive stress in the development of diabetic foot ulcers, in The Diabetic Foot, 4th ed. (Levin ME, Davidson JK, eds.), Mosby, St. Louis, MO, 1988, pp. 83–90.
Veves A, Murray HJ, Young MJ, Boulton AJM. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660–663.
Litzelman DK, Marriot DJ, Vinicor F. The role of footwear in the prevention of foot lesion in patients with NIDDH. Diabetes Care 1997;20:156–162.
Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376–1378.
Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 1986;60:763–771.
Chantelau E, Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med 1994;11:114–116.
Striesow F. Special manufactured shoes for prevention of recurrent ulcer in diabetic foot syndrome. Med Klin 1998;93:695–700.
Edmonds ME. Experience in a multidisciplinary diabetic foot clinic, in The Foot in Diabetes: proceedings of the First National Conference on the Diabetic Foot, Malvern, England, May, 1986 (Connor H, Boulton AJM, Ward JD, eds.), John Wiley, Chichester, England, 1987, pp. 121–134.
American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care 1999;22:1354–1360.
Department of Health and Human Services: Medicare payments for therapeutic shoes. August 1998 OEI-03–97–00300.
Cavanagh PR, Ulbrecht JS. Biomechanical aspects of foot problems in diabetes, in The Foot in Diabetes, 2nd ed. (Boulton AJM, Connor H, Cavanagh PR, eds.), John Wiley, New York, 1994, pp. 25–35.
Stess RM, Jensen SR, Mirmiran R. The role of dynamic plantar pressure in diabetic foot ulcers. Diabetes Care 1997;20:855–858.
Armstrong DG, Lavery LA. Evidence-based options for off-loading diabetic wounds. Clin Podiatr Med Surg 1998;15:95–104.
Caputo GM, Ulbrecht JS, Cavanagh PR. The total contact cast: a method for treating neuropathic diabetic ulcers. Am Fam Physician 1997;55:605–611.
Shaw JE, Hsi WL, Ulbrecht JS, et al. The mechanism of plantar unloading in total contact casts: implications for design and clinical use. Foot Ankle Int 1997;18:809–817.
Borssen B, Lithner F. Plaster casts in the management of advanced ischaemic and neuropathic diabetic foot lesions Diabet Med 1989;6:720–723.
Baumhauer JF, Wervey R, McWilliams J, Harris GF, Shereff MJ. A comparison study of plantar foot pressure in a standardized shoe, total contact cast, and prefabricated pneumatic walking brace. Foot Ankle Int 1997;18:26–33.
Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot’ s arthropathy in a diabetic foot specialty clinic. Diabet Med 1997;14:357–363.
Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg [Am] 1998;80:365–369.
Lavery LA, Armstrong DG, Walker SC. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot’s arthropathy. Diabet Med 1997;14:46–49.
Pinzur MS, Shields NN, Goelitz B, et al. American Orthopaedic Foot and Ankle Society shoe survey of diabetic patients. Foot Ankle Int 1999;20:703–707.
Knowles EA, Boulton AJ. Do people with diabetes wear their prescribed footwear? Diabet Med 1996;13:1064–1068.
Woolridge J, Moreno L. Evaluation of the costs to Medicare of covering therapeutic shoes for diabetic patients. Diabetes Care 1994;17:541–547.
Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of the therapeutic footwear benefit among diabetic Medicare beneficiaries in three states, 1995. Diabetes Care 1998;21:777–781.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Uccioli, L. (2002). Footwear in the Prevention of Diabetic Foot Problems. In: Veves, A., Giurini, J.M., LoGerfo, F.W. (eds) The Diabetic Foot. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-168-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-59259-168-8_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-253-7
Online ISBN: 978-1-59259-168-8
eBook Packages: Springer Book Archive